Lv12
30 积分 2023-02-14 加入
Inhibiting TROP2 in advanced non-small-cell lung cancer with sacituzumab govitecan, datopotamab deruxtecan, and sacituzumab tirumotecan: similarities and differences
2小时前
已完结
Sacituzumab Govitecan (IMMU-132), an Anti-Trop-2/SN-38 Antibody-Drug Conjugate: Characterization and Efficacy in Pancreatic, Gastric, and Other Cancers
1天前
已完结
Nuclear factor κB activity correlates with the progression and prognosis of pancreatic cancer in a mouse model
5个月前
已完结
Preclinical Combination Studies of an FGFR2 Targeted Thorium-227 Conjugate and the ATR Inhibitor BAY 1895344
5个月前
已完结
Trastuzumab-DM1 is highly effective in preclinical models of HER2-positive gastric cancer
5个月前
已完结
皖公网安备34019202002308
